HATTORI Keiichiro

Researcher's full information

Articles

• A single institutional retrospective evaluation for younger patients with primary central nervous lymphomas on a modified R-MPV regimen followed by radiotherapy and high dose cytarabine
  Hattori Keiichiro; Sakata-Yanagimoto Mamiko; Okoshi Yasu...
  Journal of Clinical and Experimental Hematopathology/57(2)/pp.41-46, 2017-10
  
  CiNii PubMed
• Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma
  Hattori Keiichiro; Sakata-Yanagimoto Mamiko; Suehara Y...
  Cancer science/109(1)/pp.225-230, 2017-11
  
  PubMed Tsukuba Repository
• MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma
  Hattori Keiichiro; Sakata-Yanagimoto Mamiko; Okoshi Yasu...
  British journal of haematology/177(3)/pp.492-494, 2017-05
  
  PubMed